RxDoctor Payments Data

Larry Burns, PA

Physician Assistant · Hugo, OKNPI 1871096958

Payments from drug & device makers

$277in general payments, 2019–2025

Across 14 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$92
  • AbbVie$46
  • Organon$36
  • Gilead$31
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
  • Boston Scientific$17
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$18567%
  • Education$9233%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$277 in reported general payments places this provider in the 50th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$27,325
Medicare patients
152
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$105,075
JardianceEmpagliflozin75$46,790
EliquisApixaban61$36,740
Combivent RespimatIpratropium/Albuterol Sulfate50$24,932
XareltoRivaroxaban27$15,825
LinzessLinaclotide26$14,561
DuleraMometasone/Formoterol18$6,476
Pantoprazole Sodium72$6,408
SynthroidLevothyroxine Sodium153$5,835
PremarinEstrogens, Conjugated18$5,195
Wixela InhubFluticasone Propion/Salmeterol30$4,735
Tamsulosin Hcl84$3,966
Fluticasone Propionate111$2,491
Novolog FlexpenInsulin Aspart11$2,473
Atorvastatin Calcium154$2,409

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Synthroid$46$20,396179 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Hugo

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →